532154 — Johnson Pharmacare Cashflow Statement
0.000.00%
- IN₹495.00m
- IN₹500.91m
- 36
- 43
- 33
- 27
Annual cashflow statement for Johnson Pharmacare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.012 | 0.967 | -13.3 | -1.96 | -5.84 |
Depreciation | |||||
Non-Cash Items | 0 | 0 | 0 | 0 | 0 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.1 | 48 | 5,005,700 | 1.51 | -13.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.08 | 49 | 5,005,687 | -0.454 | -19.1 |
Other Investing Cash Flow Items | 0 | -50.1 | -5,005,700 | 0 | 32.7 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -50.1 | -5,005,700 | 0 | 32.7 |
Financing Cash Flow Items | — | — | — | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.622 | -0.83 | 13 | 0.45 | -13.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.462 | -1.92 | -0.388 | -0.004 | 0.13 |